What can we help you find?

Leading the way in transplantation

Filter results for:

The field of organ transplantation is advancing rapidly, with Advanced Therapy Medicinal Products (ATMPs) emerging as a groundbreaking avenue for improving transplant outcomes. These innovative therapies offer new therapeutic possibilities and raise important questions regarding their clinical implementation.

To proactively address this evolving landscape, the European Society for Organ Transplantation (ESOT) has established a taskforce on ATMPs with the aim of promoting global health and access to advanced therapies. The task force was officially launched during the most recent EPITA Symposium.

 

The taskforce is led by:

Ekaterine Berishvili, Geneva, Switzerland

Olivier Thaunat, Lyon, France

ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care

Our latest publication is a position paper from the ESOT Advanced Therapy Medicinal Products (ATMP) task force. Named “ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care“, the document discusses ways to address hurdles and effectively improve access and care in this field of medicine.  ATMP

October 14, 2024 | All | Cell

Joint Statement on Hospital Exemption

This collaborative effort aims to advocate for patient access to advanced therapies, balance regulatory changes with ethical considerations, and ensure the continued progression of innovative healthcare solutions within the European

February 19, 2024 | General